| NGF | |
|---|---|
| Full Name | Nerve Growth Factor |
| Chromosome | 1p13.1 |
| Gene Type | Protein-coding gene |
| NCBI Gene ID | 4800 |
| OMIM | 162030 |
| Ensembl ID | ENSG000001116655 |
| UniProt | P01138 |
| Protein Family | Neurotrophin family |
| Receptors | TrkA (NTRK1), p75NTR (TNFRSF1B) |
| Major Pathways | PI3K/Akt, MAPK/ERK, PLCγ |
| Primary Disease Links | Alzheimer's Disease, Peripheral Neuropathy |
Nerve Growth Factor (NGF) is the founding member of the neurotrophin family of growth factors and was the first growth factor ever characterized. Discovered by Rita Levi-Montalcini and Stanley Cohen in 1956, NGF revolutionized neuroscience by demonstrating that specific molecules could control neuronal survival and differentiation. The discovery earned Levi-Montalcini the Nobel Prize in Physiology or Medicine in 1986, highlighting the fundamental importance of NGF in neurobiology. [1]
NGF is essential for the development, survival, and maintenance of specific neuronal populations in the central and peripheral nervous systems. Its role extends beyond development into adulthood, where it continues to support neuronal function and plasticity, particularly in cholinergic basal forebrain neurons that are vulnerable in Alzheimer's disease.
The NGF gene is located on chromosome 1p13.1 and contains multiple exons that allow for regulated expression. The gene structure is conserved across mammalian species, enabling comparative studies of NGF function.
Key features:
NGF is synthesized as a precursor protein (pro-NGF) that undergoes proteolytic processing:[2]
The processing ratio of pro-NGF to mature NGF is dynamically regulated and varies across:
The NGF protein adopts a fold structure characteristic of neurotrophins:
NGF forms a homodimer for biological activity, with each monomer capable of binding one TrkA receptor, leading to dimerization and activation.
NGF signals through two distinct receptor classes:[3]
TrkA is the high-affinity signaling receptor for NGF:
Receptor activation cascade:
p75NTR is the low-affinity NGF receptor:
Functions:
During embryonic development, NGF is essential for:[4]
The requirement for target-derived NGF during development is a classic example of trophic dependence.
In the adult brain, NGF continues to play critical roles:[5]
Basal forebrain cholinergic neurons (BFCNs):
Synaptic plasticity:
Neuroprotection:
In the PNS, NGF supports:[6]
NGF has intense focus in AD due to BFCN vulnerability:[5:1]
Pathological changes:
Therapeutic approaches:
Clinical trials:
NGF has shown promise in treating peripheral neuropathies.
Diabetic neuropathy:
Chemotherapy-induced neuropathy:
Huntington's Disease:
Retinitis Pigmentosa:
NGF facing significant delivery challenges:
| Challenge | Impact | Solution Approach |
|---|---|---|
| Blood-brain barrier | Poor CNS penetration | Direct CNS delivery |
| Side effects | Pain, weight loss | Targeted delivery |
| Short half-life | Frequent dosing | Sustained release systems |
| Receptor tropism | Non-specific effects | Selective targeting |
Recombinant NGF protein:
Gene therapy:
Cellular delivery:
TrkA agonists:
Pain side effects:
BBB penetration:
Dosing:
Complete NGF knockout is embryonic lethal, similar to BDNF, demonstrating essential developmental roles:
Phenotypic characteristics:
Conditional knockout models:
Transgenic overexpression:
Viral-mediated delivery:
| Compound | Mechanism | Stage | Notes |
|---|---|---|---|
| NGFC mimetics | TrkA agonist | Preclinical | Peptide-based |
| Small molecule agonists | TrkA activation | Research | Oral delivery |
| ANA-12 | TrkA antagonist | Research | Used to study NGF role |
Recombinant protein
AAV gene therapy
Gene therapy
Cellular delivery
Small molecules
Levi-Montalcini R. The nerve growth factor: thirty-five years later. Science. 1987. ↩︎
Lee R, Kermani P, Teng KK, Hempstead BL. Regulation of cell survival by secreted proneurotrophins. Science. 2001. ↩︎
Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003. ↩︎
Snider WD, Johnson EM. Neuronal survival: the paradox of neurotrophin-mediated signaling. Annu Rev Neurosci. 1994. ↩︎
Mufson EJ, Counts SE, Perez SE, Binder LI. Nerve growth factor in Alzheimer's disease: abnormal targeting and the therapeutic potential of NGF. Exp Neurol. 2003. ↩︎ ↩︎
Farinas I. Neurotrophin action on sensory neurons. Curr Opin Neurobiol. 1999. ↩︎